Liver cancer is a malignant tumor that develops in the liver, one of the body's largest and most important organs. The liver plays a vital role in digestion, metabolism, detoxification, blood clotting, and the processing of nutrients. Liver cancers can develop directly from liver cells, known as primary liver cancers, or can spread to the liver from cancers that originate in other parts of the body, known as liver metastases. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, while intrahepatic cholangiocarcinoma and other rarer tumors can also occur.
Primary liver cancer may develop in association with long-standing liver conditions such as chronic hepatitis B or C infection, cirrhosis, fatty liver disease, or other forms of chronic liver damage. However, liver cancer can also occur in people without a known history of liver disease. Early-stage liver cancer may not cause noticeable symptoms and is sometimes detected during routine surveillance or imaging performed for another reason.
As the tumor progresses, symptoms may include persistent discomfort or pain in the upper right side of the abdomen, unexplained weight loss, reduced appetite, weakness or fatigue, nausea, abdominal swelling, jaundice, itching, or a feeling of fullness after eating. Some patients may also experience worsening liver function or fluid accumulation in the abdomen. Because these symptoms can occur with several other liver and digestive conditions, appropriate medical evaluation is important.
Diagnosis usually involves a combination of clinical assessment, blood tests, liver function tests, tumor markers such as alpha-fetoprotein (AFP) in appropriate cases, and detailed imaging. Ultrasound, contrast-enhanced CT, and MRI can help identify the tumor and assess its size, number, location, and relationship with blood vessels and surrounding structures. In selected cases, a biopsy may be required to confirm the diagnosis and determine the specific type of liver tumor.
Treatment depends on the type and stage of liver cancer, the number and size of tumors, liver function, involvement of major blood vessels, whether the cancer has spread, and the patient's overall health. For selected patients with localized disease, surgical removal of the affected portion of the liver, known as liver resection or hepatectomy, may provide an opportunity for long-term disease control. In carefully selected cases, minimally invasive or laparoscopic liver surgery may be considered.
For patients with early-stage tumors who are not suitable candidates for surgical resection, other liver-directed treatments may be considered. These can include ablation procedures, transarterial therapies, or other image-guided approaches depending on the tumor characteristics and liver function. For selected patients with extensive liver disease or certain underlying liver conditions, liver transplantation may also be an appropriate treatment option.
When liver cancer is advanced or cannot be treated effectively with surgery alone, systemic treatments may be recommended. Depending on the cancer type and individual patient factors, these may include immunotherapy, targeted therapy, chemotherapy, or other specialized treatments. Treatment plans are often adjusted according to the tumor's molecular and clinical characteristics and the patient's response to therapy.
Liver metastases require a different treatment strategy because the cancer originated in another organ, such as the colon, rectum, pancreas, stomach, breast, or lung. In selected patients with limited metastatic disease, surgical removal of liver deposits may be considered, sometimes together with treatment directed at the primary cancer. A multidisciplinary evaluation is essential to determine whether surgery or other liver-directed treatment can provide meaningful disease control.
Because liver tumors can involve complex anatomy and major blood vessels, treatment planning requires specialized expertise. A multidisciplinary team involving liver and gastrointestinal surgeons, medical oncologists, radiation specialists, hepatologists, radiologists, and pathologists can assess each case and develop an individualized treatment plan.
Regular follow-up is an important part of liver cancer care. Clinical assessments, liver function tests, tumor markers when appropriate, and periodic imaging may be used to monitor treatment response and detect recurrence or progression. Early diagnosis and appropriate treatment can significantly influence the available treatment options and overall outcomes.
Comprehensive care for liver cancer focuses on accurate diagnosis, careful staging, appropriate surgical or liver-directed treatment when suitable, and personalized systemic therapy when required. Specialized multidisciplinary management helps ensure that each patient receives a treatment approach tailored to the nature and extent of the disease.